FIELD: pharmaceutical chemistry.
SUBSTANCE: group of inventions relates to pharmaceutical chemistry and includes compounds specified in cl.1 of the claims, their use, and an antibacterial composition based on them.
EFFECT: compounds, according to cl.1, used for the treatment or prevention of bacterial colonization or infection in a subject, wherein the specified bacterial infection is caused by gram-positive or gram-negative bacteria.
14 cl, 41 dwg, 47 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS AND METHODS OF TREATING INFECTIONS | 2014 |
|
RU2666540C2 |
| METHODS OF TREATING BACTERIAL INFECTIONS | 2014 |
|
RU2666605C2 |
| METHODS OF TREATING TOPICAL MICROBIAL INFECTIONS | 2014 |
|
RU2675360C2 |
| METHODS OF TREATING MICROBIAL INFECTIONS, INCLUDING MASTITIS | 2014 |
|
RU2662300C2 |
| METHODS OF TREATING PROTOZOAL INFECTIONS | 2015 |
|
RU2818168C2 |
| DRUG FOR TREATMENT OF DISEASES CAUSED BY BACTERIA | 2020 |
|
RU2754610C1 |
| INHIBITION OF BIOFILM ORGANISMS | 2010 |
|
RU2548786C2 |
| METHODS OF TREATING PROTOZOAL INFECTIONS | 2015 |
|
RU2719593C2 |
| METHOD FOR MICRO-DILUTION IN LIQUID MEDIUM FOR EVALUATING AND DETERMINING MINIMUM INHIBITORY CONCENTRATION OF ANTIBACTERIAL POLYPEPTIDES | 2017 |
|
RU2754667C2 |
| TAILORED LIPOSOMES FOR TREATMENT OF BACTERIAL INFECTIONS | 2013 |
|
RU2672106C2 |
